Clinical Trial Update: Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that Imunon is conducting Phase 1/Phase 2 study IMNN-001 (GEN-1) in newly diagnosed advanced ovarian, fallopian tube, or prim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Imunon | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1, Phase 2 | Status: RECRUITING